Constanze Heise
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Delivery of nano-formulated drugs to solid tumours is selectively increased by co-application of the vascular disrupting agent CA4P.
Journal: British journal of pharmacology
Published: October 26, 2025
Cyclic Dichalcogenides Extend the Reach of Bioreductive Prodrugs to Harness Thiol/Disulfide Oxidoreductases: Applications to seco-Duocarmycins Targeting the Thioredoxin System.
Journal: ACS central science
Published: December 08, 2022
PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor models.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 03, 2022
Self-reporting styrylthiazolium photopharmaceuticals: mitochondrial localisation as well as SAR drive biological activity.
Journal: Organic & biomolecular chemistry
Published: September 29, 2022
[5]-Helistatins: Tubulin-Binding Helicenes with Antimitotic Activity.
Journal: JACS Au
Published: August 06, 2022
Photoswitchable Epothilone-Based Microtubule Stabilisers Allow GFP-Imaging-Compatible, Optical Control over the Microtubule Cytoskeleton.
Journal: Angewandte Chemie (International ed. in English)
Published: October 28, 2021
Pyrrole Hemithioindigo Antimitotics with Near-Quantitative Bidirectional Photoswitching that Photocontrol Cellular Microtubule Dynamics with Single-Cell Precision*.
Journal: Angewandte Chemie (International ed. in English)
Published: April 07, 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours.
Journal: Nature biomedical engineering
Published: May 11, 2020
Photoswitchable paclitaxel-based microtubule stabilisers allow optical control over the microtubule cytoskeleton.
Journal: Nature communications
Published: November 14, 2019
Isoquinoline-based biaryls as a robust scaffold for microtubule inhibitors.
Journal: European journal of medicinal chemistry
Published: August 09, 2019
Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 03, 2018
Last Updated: 09/26/2026